Webinar
Rewriting the clinical and commercial rulebook with real-world data
For rare and complex diseases like brain cancer, it’s critical for patients to be identified earlier and connected to research faster. However, it’s often difficult to conduct clinical trials for rare subgroups. Real-world data (RWD) is helping to solve that.
In this webinar, experts discusses how RWD can improve early patient identification and provide evidence to guide research and regulatory decisions, enhance clinical trials for rare subgroups, and capture unique patient journeys.
- Learn how RWD provides evidence to guide research and regulatory decisions for rare diseases.
- Discover how RWD helps identify treating physicians, supports commercialization efforts, and integrates clinical and commercial strategies to accelerate drug development .
- Find out how AI helps solve challenges of leveraging RWD effectively for clinical and commercial purposes.
Unlock expert insights on real-world data
Our experts
Daniel Chancellor
VP, Thought Leadership, Norstella
Dan has over 15 years of experience across biopharma, working in roles spanning drug discovery, market analysis, competitive intelligence, and strategic consulting. He leads the thought leadership program at Norstella, where he and his team produce research and insights that help clients navigate evolving industry challenges.
Nolan Hsu
Co-founder, Brain Cancer Research Alliance
Nolan Hsu is the co-founder of the Brain Cancer Research Alliance (BCRA), a nonprofit accelerating innovation in brain cancer research. After his 2021 oligodendroglioma diagnosis and successful treatment at Dana-Farber Cancer Institute, he was inspired to help close funding gaps while continuing his work in IT leadership at biotech companies.
Suzanne Caruso
General Manager, Strategic Intelligence and Clinical & Regulatory, Norstella
Suzanne Caruso is a senior executive and clinical trial start-up expert with 15+ years in pharma. She specializes in data analytics and trial efficiency, with prior roles at Veeva Systems, WCG, GSK, and Novartis.
Lance Wolkenbrod
Senior Principal, Real-World Data Solutions, Norstella
Lance Wolkenbrod has 20+ years of experience in health and life sciences, helping manufacturers use real-world data (RWD) to solve complex business challenges. He specializes in biotech and rare diseases, building unified data models to support strategic decision making.
